Acid-base dysregulation and chemosensory mechanisms in panic disorder: A translational update

Translational Psychiatry

Volumn 5, Issue 5, 2015, Pages

  Vollmer, L L ^a   Strawn, J R ^a,b   Sah, R ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACID SENSING ION CHANNEL; CARBON DIOXIDE; DOXAPRAM; G PROTEIN COUPLED RECEPTOR; LACTATE SODIUM; OREXIN; T CELL DEATH ASSOCIATED GENE 8 RECEPTOR; UNCLASSIFIED DRUG;

ACIDOSIS; CARBON DIOXIDE BREATHING; CHEMOSENSITIVITY; DISORDERS OF ACID BASE BALANCE; FEAR; GENETICS; HUMAN; INTEROCEPTION; NERVE CELL; NEUROIMAGING; NONHUMAN; PANIC; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; PH; PROVOCATION TEST; RAPHE NUCLEUS; REVIEW; SEROTONINERGIC NERVE CELL; T LYMPHOCYTE; AUTONOMIC NERVOUS SYSTEM; CHEMORECEPTOR CELL; HYPERVENTILATION; METABOLISM; PSYCHOLOGY;

ACID-BASE IMBALANCE; ACIDOSIS; AUTONOMIC NERVOUS SYSTEM; CHEMORECEPTOR CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERVENTILATION; PANIC DISORDER;

EID: 84989282173     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.67     Document Type: Review

References (151)

1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67: 363-374.
2. Beesdo K, Pine DS, Lieb R, Wittchen H-U. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47-57.
3. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
4. Gadermann AM, Alonso J, Vilagut G, Zaslavsky AM, Kessler RC. Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depress Anxiety 2012; 29: 797-806.
5. Brown LA, Gaudiano BA, Miller IW. The impact of panic-agoraphobic comorbidity on suicidality in hospitalized patients with major depression. Depress Anxiety 2010; 27: 310-315.
6. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 629-640.
7. Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus anti-depressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007; CD004364.
8. Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst Rev 2009; CD005335.
9. Association AP Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association: Arlington, VA, USA, 2013.
10. Graeff FG, Del-Ben CM. Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev 2008; 32: 1326-1335.
11. Papp L a, Klein DF, Gorman JM. Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am J Psychiatry 1993; 150: 1149-1157.
12. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000; 157: 493-505.
13. Dresler T, Guhn A, Tupak S V, Ehlis A-C, Herrmann MJ, Fallgatter AJ et al. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm 2013; 120: 3-29.
14. Johnson PL, Federici LM, Shekhar A. Etiology triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neurosci Biobehav Rev 2014; 46P3: 429-454.
15. Wemmie JA Neurobiology of panic and pH chemosensation in the brain. Dialogues Clin Neurosci 2011; 13: 475-483.
16. Esquivel G, Schruers KR, Maddock RJ, Colasanti A, Griez EJ, KR S et al. Acids in the brain: a factor in panic? J Psychopharmacol 2010; 24: 639-647.
17. Maddock RJ The lactic acid response to alkalosis in panic disorder: an integrative review. J Neuropsychiatry Clin Neurosci 2001; 13: 22-34.
18. James W. The Principles of Psychology. Holt H: New York, NY, USA, 1890.
19. Meuret AE, Rosenfield D, Wilhelm FH, Zhou E, Conrad A, Ritz T et al. Do unexpected panic attacks occur spontaneously? Biol Psychiatry 2011; 70: 985-991.
20. Nattie E. Central chemoreceptors, pH and respiratory control. In: Kaila, K, Ransom, BR (eds). pH and Brain Function. Wiley-Liss: Wilmington, DE, USA, 1998; pp 535-560.
21. Sikter A, Frecska E, Braun I. The role of hyperventilation: hypocapnia in the pathomechanism of panic disorder. Rev Bras Psiquiatr 2007; 29: 375-379.
22. Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry 1995; 152: 666-672.
23. Maddock RJ, Buonocore MH, Copeland LE, Richards AL. Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. Mol Psychiatry 2008; 14: 537-545.
24. Ueda Y, Aizawa M, Takahashi A, Fujii M, Isaka Y. Exaggerated compensatory response to acute respiratory alkalosis in panic disorder is induced by increased lactic acid production. Nephrol Dial Transplant 2009; 24: 825-828.
25. Colasanti A, Salamon E, Schruers K, van Diest R, van Duinen M, Griez EJ. Carbon dioxide-induced emotion and respiratory symptoms in healthy volunteers. Neuropsychopharmacology 2008; 33: 3103-3110.
26. Ramirez J-M. The integrative role of the sigh in psychology, physiology, pathology, and neurobiology. Prog Brain Res 2014; 209: 91-129.
27. Klein DF False. suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993; 50: 306-317.
28. Maddock RJ, Buonocore MH, Miller AR, Yoon JH, Soosman SK, Unruh AM. Abnormal activity-dependent brain lactate and glutamate+glutamine responses in panic disorder. Biol Psychiatry 2013; 73: 1111-1119.
29. Dager SR, Friedman SD, Heide A, Layton ME, Richards T, Artru A et al. Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 1999; 56: 70-77.
30. Dager SR, Richards T, Strauss W, Artru A. Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic. Psychiatry Res 1997; 76: 89-99.
31. Damasio A, Carvalho GB. The nature of feelings: evolutionary and neurobiological origins. Nat Rev Neurosci 2013; 14: 143-152.
32. Friedman SD, Mathis CM, Hayes C, Renshaw P, Dager SR. Brain pH response to hyperventilation in panic disorder: preliminary evidence for altered acid-base regulation. Am J Psychiatry 2006; 163: 710-715.
33. Goossens L, Leibold N, Peeters R, Esquivel G, Knuts I, Backes W et al. Brainstem response to hypercapnia: a symptom provocation study into the pathophysiology of panic disorder. J Psychopharmacol 2014; 28: 449-456.
34. Magnotta VA, Heo H-YY, Dlouhy BJ, Dahdaleh NS, Follmer RL, Thedens DR et al. Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci USA 2012; 109: 8270-8273.
35. Magnotta VA, Johnson CP, Follmer R, Wemmie JA. Functional t1ρ imaging in panic disorder. Biol Psychiatry 2014; 75: 884-891.
36. Rassovsky Y, Kushner MG. Carbon dioxide in the study of panic disorder: Issues of definition, methodology, and outcome. J Anxiety Disord 2003; 17: 1-32.
37. Cohen ME, White PD. Life situations, emotions, and neurocirculatory asthenia (anxiety neurosis, neurasthenia, effort syndrome). Psychosom Med 1951; 13: 335-357.
38. Pitts FN, McClure JN, Pitts FN Jr, McClure JN Jr Lactate metabolism in anxiety neurosis. N Engl J Med 1967; 277: 1329-1336.
39. Lee Y-LJ, Curtis GC, Weg JG, Abelson JL, Modell JG, Campbell KM. Panic attacks induced by doxapram. Biol Psychiatry 1993; 33: 295-297.
40. Balon R, Yeragani VK, Pohl R, Muench J, Berchou R. Somatic and psychological symptoms during isoproterenol-induced panic attacks. Psychiatry Res 1990; 32: 103-112.
41. Vilarim MM, Rocha Araujo DM, Nardi AE. Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother 2011; 11: 1185-1195.
42. Griez E, Schruers K. Experimental pathophysiology of panic. J Psychosom Res 1998; 45: 493-503.
43. De Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 1989; 46: 511-517.
44. Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47: 917-925.
45. Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety: II Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) 1987; 92: 14-24.
46. Maremmani I, Marini G, Fornai F. Naltrexone-induced panic attacks. Am J Psychiatry 1998; 155: 447.
47. Kent JM, Papp LA, Martinez JM, Browne ST, Coplan JD, Klein DF et al. Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am J Psychiatry 2001; 158: 58-67.
48. Talesnik B, Berzak E, Ben-Zion I, Kaplan Z, Benjamin J. Sensitivity to carbon dioxide in drug-naïve subjects with post-traumatic stress disorder. J Psychiatr Res 2007; 41: 451-454.
49. Do Amaral JMX, Spadaro PTM, Pereira VM, de Oliveira e Silva AC, Nardi AE. The carbon dioxide challenge test in panic disorder: a systematic review of preclinical and clinical research. Rev Bras Psiquiatr 2013; 35: 318-331.
50. Leibold NK, Viechtbauer W, Goossens L, De Cort K, Griez EJ, Myin-Germeys I et al. Carbon dioxide inhalation as a human experimental model of panic: the relationship between emotions and cardiovascular physiology. Biol Psychol 2013; 94: 331-340.
51. Huckstepp RTR, Dale N. Redefining the components of central CO2 chemosensitivity-towards a better understanding of mechanism. J Physiol 2011; 589: 5561-5579.
52. Sanderson WC, Wetzler S. Five percent carbon dioxide challenge: Valid analogue and marker of panic disorder? Biol Psychiatry 1990; 27: 689-701.
53. Mathew RJ, Wilson WH, Tant S. Responses to hypercarbia induced by acetazolamide in panic disorder patients. Am J Psychiatry 1989; 146: 996-1000.
54. Gorman JM, Papp LA, Coplan J, Martinez J, Liebowitz MR, Klein DF. The effect of acetazolamide on ventilation in panic disorder patients. Am J Psychiatry 1993; 150: 1480-1484.
55. Kelly MM, Forsyth JP, Karekla M. Sex differences in response to a panicogenic challenge procedure: an experimental evaluation of panic vulnerability in a non-clinical sample. Behav Res Ther 2006; 44: 1421-1430.
56. Bunaciu L, Feldner MT, Babson K a, Zvolensky MJ, Eifert GH. Biological sex and panic-relevant anxious reactivity to abrupt increases in bodily arousal as a function of biological challenge intensity. J Behav Ther Exp Psychiatry 2012; 43: 526-531.
57. Nillni YI, Berenz EC, Rohan KJ, Zvolensky MJ. Sex differences in panic-relevant responding to a 10% carbon dioxide-enriched air biological challenge. J Anxiety Disord 2012; 26: 165-172.
58. Nardi AE, Valença AM, Lopes FL, de-Melo-Neto VL, Freire RC, Veras AB et al. Caffeine and 35% carbon dioxide challenge tests in panic disorder. Hum Psychopharmacol 2007; 22: 231-240.
59. Griez EJ, Colasanti A, van Diest R, Salamon E, Schruers K. Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity. PLoS One 2007; 2: e987.
60. Van den Hout MA, van der Molen GM, Griez E, Lousberg H, Nansen A. Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure. Am J Psychiatry 1987; 144: 788-791.
61. Prenoveau JM, Forsyth JP, Kelly MM, Barrios V. Repeated exposure to 20% CO2 challenge and risk for developing panic attacks: a controlled 6- and 12-month follow-up in a nonclinical sample. J Anxiety Disord 2006; 20: 1158-1167.
62. Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L. Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol 2002; 22: 300-308.
63. Bailey JE, Papadopoulos A, Seddon K, Nutt DJ. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO (2) models of experimental human anxiety. J Psychopharmacol 2009; 23: 117-122.
64. Bailey JE, Papadopoulos A, Diaper A, Phillips S, Schmidt M, van der Ark P et al. Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety. J Psychopharmacol 2011; 25: 1199-1206.
65. Poma SZ, Merlo-Pich E, Bettica P, Bani M, Fina P, Ziviani L et al. Anxiolytic effects of vestipitant in a sub-group of healthy volunteers known to be sensitive to CO2 challenge. J Psychopharmacol 2014; 28: 491-497.
66. Gorman JM, Battista D, Goetz RR, Dillon DJ, Liebowitz MR, Fyer AJ et al. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch Gen Psychiatry 1989; 46: 145-150.
67. Goetz RR, Klein DF, Gorman JM. Consistencies between recalled panic and lactate-induced panic. Anxiety 1994; 1: 31-36.
68. Carr DB, Sheehan D V, Surman OS, Coleman JH, Greenblatt DJ, Heninger GR et al. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry 1986; 143: 483-494.
69. Cowley DS, Dager SR, Roy-Byrne PP, Avery DH, Dunner DL. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder. Biol Psychiatry 1991; 30: 49-56.
70. Rifkin A, Klein DF, Dillon D, Levitt M. Blockade by imipramine or desipramine of panic induced by sodium lactate. Am J Psychiatry 1981; 138: 676-677.
71. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16: 877-885.
72. Van Hall G, Strømstad M, Rasmussen P, Jans O, Zaar M, Gam C et al. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 2009; 29: 1121-1129.
73. Dager SR, Rainey JM, Kenny MA, Artru AA, Metzger GD, Bowden DM. Central nervous system effects of lactate infusion in primates. Biol Psychiatry 1990; 27: 193-204.
74. Peskind ER, Jensen CF, Pascualy M, Tsuang D, Cowley D, Martin DC et al. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biol Psychiatry 1998; 44: 1007-1016.
75. Seier FE, Kellner M, Yassouridis A, Heese R, Strian F, Wiedemann K. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. Am J Physiol 1997; 272: H2630-H2638.
76. Layton ME, Friedman SD, Dager SR. Brain metabolic changes during lactateinduced panic: Effects of gabapentin treatment. Depress Anxiety 2001; 14: 251-254.
77. Ströhle A, Romeo E, di Michele F, Pasini A, Hermann B, Gajewsky G et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry 2003; 60: 161-168.
78. Ward JW, Franko BV. A new centrally acting agent (AHR-619) with marked respiratory stimulant, pressor and awakening effects. Fed Proc 1962; 21: 325.
79. Burki NK Ventilatory effects of doxapram in conscious human subjects. Chest 1984; 85: 600-604.
80. Gutman DA, Coplan J, Papp L, Martinez J, Gorman J. Doxapram-induced panic attacks and cortisol elevation. Psychiatry Res 2005; 133: 253-261.
81. Abelson JL, Nesse RM, Weg JG, Curtis GC. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med 1996; 58: 302-313.
82. Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM et al. The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol 2007; 17: 672-686.
83. Cotten JF, Keshavaprasad B, Laster MJ, Eger EI II, Yost CS. The ventilatory stimulant doxapram inhibits TASK tandem pore (K 2 P) potassium channel function but does not affect minimum alveolar anesthetic concentration. Anesth Analg 2006; 102: 779-785.
84. Washburn CP, Sirois JE, Talley EM, Guyenet PG, Bayliss DA. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J Neurosci 2002; 22: 1256-1265.
85. Yost CS A new look at the respiratory stimulant doxapram. CNS Drug Rev 2006; 12: 236-249.
86. Pauls DL, Noyes R, Crowe RR. The familial prevalence in second-degree relatives of patients with anxiety neurosis (panic disorder). J Affect Disord 1979; 1: 279-285.
87. Perna G, Cocchi S, Bertani A, Arancio C, Bellodi L. Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry 1995; 152: 623-625.
88. Coryell W. Hypersensitivity to carbon dioxide as a disease-specific trait marker. Biol Psychiatry 1997; 41: 259-263.
89. Bellodi L, Perna G, Caldirola D, Arancio C, Bertani A, Di Bella D. CO2-induced panic attacks: a twin study. Am J Psychiatry 1998; 155: 1184-1188.
90. Battaglia M, Pesenti-Gritti P, Spatola CAM, Ogliari A, Tambs K. A twin study of the common vulnerability between heightened sensitivity to hypercapnia and panic disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 586-593.
91. Roberson-Nay R, Berenz EC, Acierno R, Tran TL, Trung LT, Tam NT et al. Characteristics of individuals meeting criteria for new onset panic attacks following exposure to a typhoon. Psychiatry Res 2013; 209: 574-578.
92. Battaglia M, Pesenti-Gritti P, Medland SE, Ogliari A, Tambs K, Spatola CAM A genetically informed study of the association between childhood separation anxiety, sensitivity to CO(2), panic disorder, and the effect of childhood parental loss. Arch Gen Psychiatry 2009; 66: 64-71.
93. D'Amato FR, Zanettini C, Lampis V, Coccurello R, Pascucci T, Ventura R et al. Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay. PLoS One 2011; 6: e18637.
94. Roberson-Nay R, Klein DF, Klein RG, Mannuzza S, Moulton JL, Guardino M et al. Carbon dioxide hypersensitivity in separation-anxious offspring of parents with panic disorder. Biol Psychiatry 2010; 67: 1171-1177.
95. Battaglia M, Ogliari A, D'Amato F, Kinkead R. Early-life risk factors for panic and separation anxiety disorder: Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. Neurosci Biobehav Rev 2014; 46P3: 455-464.
96. Abe R, Watanabe Y, Tachibana A, Nunokawa A, Shindo M, Hasegawa N et al. Exploration of a possible association between the tryptophan hydroxylase 2 (TPH2) gene and panic symptoms induced by carbon dioxide in healthy individuals. Psychiatry Res 2012; 197: 358-359.
97. Gyawali S, Subaran R, Weissman MM, Hershkowitz D, McKenna MC, Talati A et al. Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder. Biol Psychiatry 2010; 67: 331-338.
98. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W et al. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 2010; 15: 166-176.
99. Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J et al. Association of the functional - 1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3T fMRI in panic disorder. Int J Neuropsychopharmacol 2006; 9: 349-355.
100. Kim Y-K, Lee H-J, Yang J-C, Hwang J-A, Yoon H-K. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 2009; 39: 170-175.
101. Perkins AM, Ettinger U, Williams SCR, Reuter M, Hennig J, Corr PJ. Flight behaviour in humans is intensified by a candidate genetic risk factor for panic disorder: evidence from a translational model of fear and anxiety. Mol Psychiatry 2011; 16: 242-244.
102. Paul ED, Johnson PL, Shekhar A, Lowry CA. The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neurosci Biobehav Rev 2014; 46: 379-396.
103. Reschke AH, Mannuzza S, Chapman TF, Lipsitz JD, Liebowitz MR, Gorman JM et al. Sodium lactate response and familial risk for panic disorder. Am J Psychiatry 1995; 152: 277-279.
104. Philibert RA, Nelson JJ, Sandhu HK, Crowe RR, Coryell WH. Association of an exonic LDHA polymorphism with altered respiratory response in probands at high risk for panic disorder. Am J Med Genet B Neuropsychiatr Genet 2003; 117B: 11-17.
105. Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ et al. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry 2014; 76: 902-910.
106. Putnam RW CO2 chemoreception in cardiorespiratory control. J Appl Physiol 2010; 108: 1796-1802.
107. Kinkead R, Tenorio L, Drolet G, Bretzner F, Gargaglioni L. Respiratory manifestations of panic disorder in animals and humans: a unique opportunity to understand how supramedullary structures regulate breathing. Respir Physiol Neurobiol 2014; 204: 3-13.
108. 2 evoked behavior and physiology: relevance to panic. In: Society for Neuroscience Abstracts 2012.
109. Wemmie JA, Askwith CC, Lamani E, Cassell MD, Freeman JH, Welsh MJ. Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. J Neurosci 2003; 23: 5496-5502.
110. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002; 26: 321-352.
111. Ziemann AE, Allen JE, Dahdaleh NS, Drebot II, Coryell MW, Wunsch AM et al. The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior. Cell 2009; 139: 1012-1021.
112. Coryell MW, Ziemann AE, Westmoreland PJ, Haenfler JM, Kurjakovic Z, Zha X et al. Targeting ASIC1a reduces innate fear and alters neuronal activity in the fear circuit. Biol Psychiatry 2007; 62: 1140-1148.
113. Feinstein JS, Buzza C, Hurlemann R, Follmer RL, Dahdaleh NS, Coryell WH et al. Fear and panic in humans with bilateral amygdala damage. Nat Neurosci 2013; 16: 270-272.
114. Feinstein JS, Adolphs R, Damasio A, Tranel D. The human amygdala and the induction and experience of fear. Curr Biol 2011; 21: 34-38.
115. Johnson PL, Shekhar A. An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiol Behav 2012; 107: 686-698.
116. Shekhar A, Keim SRR, Simon JRR, McBride WJJ Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol Biochem Behav 1996; 55: 249-256.
117. Wilent WB, Oh MY, Buetefisch CM, Bailes JE, Cantella D, Angle C et al. Induction of panic attack by stimulation of the ventromedial hypothalamus. J Neurosurg 2010; 112: 1295-1298.
118. Shekhar A, Keim SR. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 1997; 17: 9726-9735.
119. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S et al. A key role for orexin in panic anxiety. Nat Med 2010; 16: 111-115.
120. Shekhar A, Johnson PL, Sajdyk TJ, Fitz SD, Keim SR, Kelley PE et al. Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J Neurosci 2006; 26: 9205-9215.
121. Fukuda Y, Sato A, Suzuki A, Trzebski A. Autonomic nerve and cardiovascular responses to changing blood oxygen and carbon dioxide levels in the rat. J Auton Nerv Syst 1989; 28: 61-74.
122. De Lecea L, Kilduff TS, Peyron C, Gao X-B, Foye PE, Danielson PE et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-327.
123. Deng B-S, Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T. Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice. J Appl Physiol 2007; 103: 1772-1779.
124. Johnson PL, Samuels BC, Fitz SD, Lightman SL, Lowry CA, Shekhar A. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology 2012; 37: 1911-1922.
125. Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas C V. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014; 8: 36.
126. Richerson GB Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 2004; 5: 449-461.
127. Severson C a, Wang W, Pieribone V a, Dohle CI, Richerson GB. Midbrain ser-otonergic neurons are central pH chemoreceptors. Nat Neurosci 2003; 6: 1139-1140.
128. Bradley SR, Pieribone VA, Wang W, Severson CA, Jacobs RA, Richerson GB. Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nat Neurosci 2002; 5: 401-402.
129. Buchanan GF, Richerson GB. Role of chemoreceptors in mediating dyspnea. Respir Physiol Neurobiol 2009; 167: 9-19.
130. Iceman KE, Harris MB. A group of non-serotonergic cells is CO2-stimulated in the medullary raphé. Neuroscience 2014; 259: 203-213.
131. Colasanti A, Esquivel G, den Boer E, Horlings A, Dandachi A, Oostwegel JL et al. Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers. Psychopharmacology (Berl) 2011; 215: 739-748.
132. Choi JW, Lee SY, Choi Y. Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells. Cell Immunol 1996; 168: 78-84.
133. Kyaw H, Zeng Z, Su K, Fan P, Shell BK, Carter KC et al. Cloning, characterization, and mapping of human homolog of mouse T-cell death-associated gene. DNA Cell Biol 1998; 17: 493-500.
134. McGuire J, Herman JP, Ghosal S, Eaton K, Sallee FR, Sah R et al. Acid-sensing by the T cell death-associated gene 8 (TDAG8) receptor cloned from rat brain. Biochem Biophys Res Commun 2009; 386: 420-425.
135. Ishii S, Kihara Y, Shimizu T. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J Biol Chem 2005; 280: 9083-9087.
136. Ludwig M, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U et al. Protonsensing G-protein-coupled receptors. Nature 2003; 425: 93-98.
137. Radu CG, Nijagal A, McLaughlin J, Wang L, Witte ON. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc Natl Acad Sci USA 2005; 102: 1632-1637.
138. Wang J-Q, Kon J, Mogi C, Tobo M, Damirin A, Sato K et al. TDAG8 is a protonsensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 2004; 279: 45626-45633.
139. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993; 7: 678-686.
140. Sisó S, Jeffrey M. González L. Sensory circumventricular organs in health and disease. Acta Neuropathol 2010; 120: 1-17.
141. Vollmer LE, Ghosal S, Li K-Y, Putnam R, Sah R. Acid Sensing T-Cell Death Associated Gene-8 (TDAG8) Receptor in CO2 Evoked Fear: Relevance to Panic Pathophysiology. In: Society for Neroscience Abstracts 2011.
142. Schenberg LC, Bittencourt a S, Sudré EC, Vargas LC. Modeling panic attacks. Neurosci Biobehav Rev 2001; 25: 647-659.
143. Moreira FA, Gobira PH, Viana TG, Vicente MA, Zangrossi H, Graeff FG. Modeling panic disorder in rodents. Cell Tissue Res 2013; 354: 119-125.
144. Nashold BS, Wilson WP, Slaughter DG. Sensations evoked by stimulation in the midbrain of man. J Neurosurg 1969; 30: 14-24.
145. Protopopescu X, Pan H, Tuescher O, Cloitre M, Goldstein M, Engelien A et al. Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport 2006; 17: 361-363.
146. Uchida RR, Del-Ben CM, Busatto GF, Duran FLS, Guimarães FS, Crippa JAS et al. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res 2008; 163: 21-29.
147. Schimitel FG, de Almeida GM, Pitol DN, Armini RS, Tufik S, Schenberg LC. Evidence of a suffocation alarm system within the periaqueductal gray matter of the rat. Neuroscience 2012; 200: 59-73.
148. Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neurosci 2013; 14: 461-471.
149. Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI et al. Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain 2013; 136: 106-115.
150. Klein DF, Papp LA, Gorman JM. Acetazolamide as a control for CO2-induced panic. Am J Psychiatry 1990; 147: 677-678.
151. Klein DF Testing the suffocation false alarm theory of panic disorder. Anxiety 1994; 1: 1-7.